Legal & General Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $551M | Buy |
1,882,311
+15,942
| +0.9% | +$5.24M | 0.13% | 149 |
|
|
2025
Q4 | $654M | Sell |
1,866,369
-54,984
| -3% | -$18.6M | 0.15% | 119 |
|
|
2025
Q3 | $621M | Buy |
1,921,353
+88,254
| +5% | +$27.4M | 0.14% | 127 |
|
|
2025
Q2 | $713M | Buy |
1,833,099
+37,550
| +2% | +$15.1M | 0.18% | 105 |
|
|
2025
Q1 | $781M | Buy |
1,795,549
+42,143
| +2% | +$16.9M | 0.21% | 88 |
|
|
2024
Q4 | $647M | Sell |
1,753,406
-44,489
| -2% | -$18.6M | 0.17% | 104 |
|
|
2024
Q3 | $935M | Buy |
1,797,895
+16,642
| +0.9% | +$8.89M | 0.25% | 69 |
|
|
2024
Q2 | $965M | Sell |
1,781,253
-23,307
| -1% | -$12.3M | 0.27% | 61 |
|
|
2024
Q1 | $936M | Sell |
1,804,560
-13,884
| -0.8% | -$6.9M | 0.27% | 66 |
|
|
2023
Q4 | $858M | Buy |
1,818,444
+28,317
| +2% | +$13.1M | 0.27% | 64 |
|
|
2023
Q3 | $779M | Sell |
1,790,127
-55,284
| -3% | -$25.1M | 0.27% | 63 |
|
|
2023
Q2 | $820M | Sell |
1,845,411
-11,335
| -0.6% | -$5.23M | 0.27% | 66 |
|
|
2023
Q1 | $854M | Buy |
1,856,746
+15,457
| +0.8% | +$7.36M | 0.31% | 58 |
|
|
2022
Q4 | $945M | Sell |
1,841,289
-58,479
| -3% | -$29.7M | 0.36% | 48 |
|
|
2022
Q3 | $863M | Sell |
1,899,768
-91,477
| -5% | -$43.8M | 0.34% | 52 |
|
|
2022
Q2 | $961M | Sell |
1,991,245
-13,954
| -0.7% | -$6.9M | 0.34% | 52 |
|
|
2022
Q1 | $985M | Buy |
2,005,199
+91,185
| +5% | +$41.7M | 0.3% | 61 |
|
|
2021
Q4 | $887M | Sell |
1,914,014
-47,197
| -2% | -$19.9M | 0.27% | 70 |
|
|
2021
Q3 | $731M | Buy |
1,961,211
+59,922
| +3% | +$22.8M | 0.24% | 84 |
|
|
2021
Q2 | $726M | Buy |
1,901,289
+61,658
| +3% | +$23.6M | 0.24% | 82 |
|
|
2021
Q1 | $660M | Sell |
1,839,631
-30,045
| -2% | -$9.66M | 0.25% | 80 |
|
|
2020
Q4 | $600M | Sell |
1,869,676
-17,050
| -0.9% | -$5.23M | 0.24% | 82 |
|
|
2020
Q3 | $507M | Buy |
1,886,726
+62,053
| +3% | +$16.7M | 0.23% | 83 |
|
|
2020
Q2 | $480M | Buy |
1,824,673
+17
| +0% | +$4.54K | 0.23% | 80 |
|
|
2020
Q1 | $415M | Buy |
1,824,656
+79,297
| +5% | +$21.6M | 0.24% | 80 |
|
|
2019
Q4 | $527M | Sell |
1,745,359
-816
| -0% | -$225K | 0.25% | 78 |
|
|
2019
Q3 | $419M | Buy |
1,746,175
+8,036
| +0.5% | +$2.2M | 0.22% | 94 |
|
|
2019
Q2 | $490M | Buy |
1,738,139
+18,600
| +1% | +$5.08M | 0.26% | 75 |
|
|
2019
Q1 | $493M | Buy |
1,719,539
+289,561
| +20% | +$83.7M | 0.28% | 71 |
|
|
2018
Q4 | $376M | Buy |
1,429,978
+107,132
| +8% | +$29.5M | 0.29% | 72 |
|
|
2018
Q3 | $363M | Buy |
1,322,846
+34,478
| +3% | +$8.95M | 0.26% | 81 |
|
|
2018
Q2 | $307M | Sell |
1,288,368
-74,482
| -5% | -$17.2M | 0.24% | 86 |
|
|
2018
Q1 | $299M | Sell |
1,362,850
-157,433
| -10% | -$37M | 0.23% | 93 |
|
|
2017
Q4 | $342M | Sell |
1,520,283
-87,125
| -5% | -$18.6M | 0.25% | 87 |
|
|
2017
Q3 | $305M | Buy |
1,607,408
+15,731
| +1% | +$2.99M | 0.23% | 97 |
|
|
2017
Q2 | $299M | Buy |
1,591,677
+105,806
| +7% | +$19M | 0.24% | 94 |
|
|
2017
Q1 | $246M | Buy |
1,485,871
+98,189
| +7% | +$15.6M | 0.21% | 109 |
|
|
2016
Q4 | $200M | Buy |
1,387,682
+17,328
| +1% | +$2.32M | 0.19% | 130 |
|
|
2016
Q3 | $172M | Buy |
1,370,354
+3,007
| +0.2% | +$388K | 0.17% | 139 |
|
|
2016
Q2 | $180M | Buy |
1,367,347
+54,243
| +4% | +$7.42M | 0.19% | 124 |
|
|
2016
Q1 | $182M | Buy |
1,313,104
+11,822
| +0.9% | +$1.58M | 0.2% | 115 |
|
|
2015
Q4 | $181M | Sell |
1,301,282
-24,180
| -2% | -$3.33M | 0.21% | 114 |
|
|
2015
Q3 | $186M | Buy |
1,325,462
+45,573
| +4% | +$6.85M | 0.23% | 103 |
|
|
2015
Q2 | $210M | Sell |
1,279,889
-5,146
| -0.4% | -$822K | 0.25% | 95 |
|
|
2015
Q1 | $198M | Sell |
1,285,035
-24,346
| -2% | -$3.47M | 0.24% | 97 |
|
|
2014
Q4 | $165M | Sell |
1,309,381
-56,457
| -4% | -$6.98M | 0.19% | 124 |
|
|
2014
Q3 | $163M | Sell |
1,365,838
-46,314
| -3% | -$5.31M | 0.2% | 123 |
|
|
2014
Q2 | $152M | Buy |
1,412,152
+18,848
| +1% | +$1.94M | 0.18% | 134 |
|
|
2014
Q1 | $139M | Sell |
1,393,304
-24,813
| -2% | -$2.24M | 0.17% | 145 |
|
|
2013
Q4 | $131M | Sell |
1,418,117
-60,042
| -4% | -$5.34M | 0.16% | 150 |
|
|
2013
Q3 | $124M | Sell |
1,478,159
-20,333
| -1% | -$1.74M | 0.16% | 147 |
|
|
2013
Q2 | $123M | Buy |
+1,498,492
| New | +$112M | 0.17% | 140 |
|
Other funds holding ELV
VCM
VPM
Legal & General Group's ELV Position: Q1 2026 in Review
Legal & General Group increased its Elevance Health (ELV) stake by 0.85% in Q1 2026, buying an estimated $5.24M and bringing the position to 1,882,311 shares worth $551M. The position accounts for 0.13% of the portfolio, ranked #149.
Legal & General Group first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $985M in Q1 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Legal & General Group held 1,882,311 shares of Elevance Health worth $551M as of Q1 2026.
- Legal & General Group bought 15,942 Elevance Health shares in Q1 2026, an estimated $5.24M.
- Elevance Health made up 0.13% of Legal & General Group's portfolio in Q1 2026, its #149 holding.
- Legal & General Group first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Legal & General Group's Elevance Health position peaked at $985M in Q1 2022.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.